Global Rapid Diagnostic Testing for Influenza Market Research Report 2022

SKU ID : QYR-21522013 | Publishing Date : 23-Aug-2022 | No. of pages : 103

Detailed TOC of Global Rapid Diagnostic Testing for Influenza Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Digital RIDTs
        1.2.3 Conventional RIDT
    1.3 Market by Application
        1.3.1 Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 POCT
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Rapid Diagnostic Testing for Influenza Market Perspective (2017-2028)
    2.2 Rapid Diagnostic Testing for Influenza Growth Trends by Region
        2.2.1 Rapid Diagnostic Testing for Influenza Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Rapid Diagnostic Testing for Influenza Historic Market Size by Region (2017-2022)
        2.2.3 Rapid Diagnostic Testing for Influenza Forecasted Market Size by Region (2023-2028)
    2.3 Rapid Diagnostic Testing for Influenza Market Dynamics
        2.3.1 Rapid Diagnostic Testing for Influenza Industry Trends
        2.3.2 Rapid Diagnostic Testing for Influenza Market Drivers
        2.3.3 Rapid Diagnostic Testing for Influenza Market Challenges
        2.3.4 Rapid Diagnostic Testing for Influenza Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue
        3.1.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue (2017-2022)
        3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2017-2022)
    3.2 Global Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Rapid Diagnostic Testing for Influenza Revenue
    3.4 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio
        3.4.1 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rapid Diagnostic Testing for Influenza Revenue in 2021
    3.5 Rapid Diagnostic Testing for Influenza Key Players Head office and Area Served
    3.6 Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service
    3.7 Date of Enter into Rapid Diagnostic Testing for Influenza Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Diagnostic Testing for Influenza Breakdown Data by Type
    4.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Type (2017-2022)
    4.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2023-2028)
5 Rapid Diagnostic Testing for Influenza Breakdown Data by Application
    5.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Application (2017-2022)
    5.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Rapid Diagnostic Testing for Influenza Market Size (2017-2028)
    6.2 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022)
    6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Rapid Diagnostic Testing for Influenza Market Size (2017-2028)
    7.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022)
    7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size (2017-2028)
    8.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022)
    8.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Rapid Diagnostic Testing for Influenza Market Size (2017-2028)
    9.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022)
    9.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size (2017-2028)
    10.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022)
    10.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 BD
        11.1.1 BD Company Detail
        11.1.2 BD Business Overview
        11.1.3 BD Rapid Diagnostic Testing for Influenza Introduction
        11.1.4 BD Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.1.5 BD Recent Development
    11.2 Abbot (Alere)
        11.2.1 Abbot (Alere) Company Detail
        11.2.2 Abbot (Alere) Business Overview
        11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Introduction
        11.2.4 Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.2.5 Abbot (Alere) Recent Development
    11.3 Quidel
        11.3.1 Quidel Company Detail
        11.3.2 Quidel Business Overview
        11.3.3 Quidel Rapid Diagnostic Testing for Influenza Introduction
        11.3.4 Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.3.5 Quidel Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche Rapid Diagnostic Testing for Influenza Introduction
        11.4.4 Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 Thermo Fisher Scientific
        11.5.1 Thermo Fisher Scientific Company Detail
        11.5.2 Thermo Fisher Scientific Business Overview
        11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Introduction
        11.5.4 Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.5.5 Thermo Fisher Scientific Recent Development
    11.6 Meridian Bioscience
        11.6.1 Meridian Bioscience Company Detail
        11.6.2 Meridian Bioscience Business Overview
        11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Introduction
        11.6.4 Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.6.5 Meridian Bioscience Recent Development
    11.7 Analytik Jena
        11.7.1 Analytik Jena Company Detail
        11.7.2 Analytik Jena Business Overview
        11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Introduction
        11.7.4 Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.7.5 Analytik Jena Recent Development
    11.8 Princeton BioMeditech Corporation
        11.8.1 Princeton BioMeditech Corporation Company Detail
        11.8.2 Princeton BioMeditech Corporation Business Overview
        11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Introduction
        11.8.4 Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.8.5 Princeton BioMeditech Corporation Recent Development
    11.9 BioMerieux
        11.9.1 BioMerieux Company Detail
        11.9.2 BioMerieux Business Overview
        11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Introduction
        11.9.4 BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.9.5 BioMerieux Recent Development
    11.10 Sekisui Diagnostics
        11.10.1 Sekisui Diagnostics Company Detail
        11.10.2 Sekisui Diagnostics Business Overview
        11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Introduction
        11.10.4 Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.10.5 Sekisui Diagnostics Recent Development
    11.11 Response Biomedical
        11.11.1 Response Biomedical Company Detail
        11.11.2 Response Biomedical Business Overview
        11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Introduction
        11.11.4 Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.11.5 Response Biomedical Recent Development
    11.12 SA Scientific
        11.12.1 SA Scientific Company Detail
        11.12.2 SA Scientific Business Overview
        11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Introduction
        11.12.4 SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.12.5 SA Scientific Recent Development
    11.13 DiaSorin (Focus Diagnostics)
        11.13.1 DiaSorin (Focus Diagnostics) Company Detail
        11.13.2 DiaSorin (Focus Diagnostics) Business Overview
        11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Introduction
        11.13.4 DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.13.5 DiaSorin (Focus Diagnostics) Recent Development
    11.14 Wondfo
        11.14.1 Wondfo Company Detail
        11.14.2 Wondfo Business Overview
        11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Introduction
        11.14.4 Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.14.5 Wondfo Recent Development
    11.15 Beijing Wantai Biological Pharmacy
        11.15.1 Beijing Wantai Biological Pharmacy Company Detail
        11.15.2 Beijing Wantai Biological Pharmacy Business Overview
        11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Introduction
        11.15.4 Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022)
        11.15.5 Beijing Wantai Biological Pharmacy Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Rapid Diagnostic Testing for Influenza Market Research Report 2022

List of Tables
    Table 1. Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Digital RIDTs
    Table 3. Key Players of Conventional RIDT
    Table 4. Global Rapid Diagnostic Testing for Influenza Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Rapid Diagnostic Testing for Influenza Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Rapid Diagnostic Testing for Influenza Market Share by Region (2017-2022)
    Table 8. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Rapid Diagnostic Testing for Influenza Market Share by Region (2023-2028)
    Table 10. Rapid Diagnostic Testing for Influenza Market Trends
    Table 11. Rapid Diagnostic Testing for Influenza Market Drivers
    Table 12. Rapid Diagnostic Testing for Influenza Market Challenges
    Table 13. Rapid Diagnostic Testing for Influenza Market Restraints
    Table 14. Global Rapid Diagnostic Testing for Influenza Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Rapid Diagnostic Testing for Influenza Market Share by Players (2017-2022)
    Table 16. Global Top Rapid Diagnostic Testing for Influenza Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2021)
    Table 17. Ranking of Global Top Rapid Diagnostic Testing for Influenza Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Rapid Diagnostic Testing for Influenza Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service
    Table 21. Date of Enter into Rapid Diagnostic Testing for Influenza Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Rapid Diagnostic Testing for Influenza Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2017-2022)
    Table 25. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2023-2028)
    Table 27. Global Rapid Diagnostic Testing for Influenza Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2017-2022)
    Table 29. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2023-2028)
    Table 31. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2023-2028) & (US$ Million)
    Table 41. BD Company Detail
    Table 42. BD Business Overview
    Table 43. BD Rapid Diagnostic Testing for Influenza Product
    Table 44. BD Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 45. BD Recent Development
    Table 46. Abbot (Alere) Company Detail
    Table 47. Abbot (Alere) Business Overview
    Table 48. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product
    Table 49. Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 50. Abbot (Alere) Recent Development
    Table 51. Quidel Company Detail
    Table 52. Quidel Business Overview
    Table 53. Quidel Rapid Diagnostic Testing for Influenza Product
    Table 54. Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 55. Quidel Recent Development
    Table 56. Roche Company Detail
    Table 57. Roche Business Overview
    Table 58. Roche Rapid Diagnostic Testing for Influenza Product
    Table 59. Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 60. Roche Recent Development
    Table 61. Thermo Fisher Scientific Company Detail
    Table 62. Thermo Fisher Scientific Business Overview
    Table 63. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product
    Table 64. Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 65. Thermo Fisher Scientific Recent Development
    Table 66. Meridian Bioscience Company Detail
    Table 67. Meridian Bioscience Business Overview
    Table 68. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product
    Table 69. Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 70. Meridian Bioscience Recent Development
    Table 71. Analytik Jena Company Detail
    Table 72. Analytik Jena Business Overview
    Table 73. Analytik Jena Rapid Diagnostic Testing for Influenza Product
    Table 74. Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 75. Analytik Jena Recent Development
    Table 76. Princeton BioMeditech Corporation Company Detail
    Table 77. Princeton BioMeditech Corporation Business Overview
    Table 78. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product
    Table 79. Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 80. Princeton BioMeditech Corporation Recent Development
    Table 81. BioMerieux Company Detail
    Table 82. BioMerieux Business Overview
    Table 83. BioMerieux Rapid Diagnostic Testing for Influenza Product
    Table 84. BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 85. BioMerieux Recent Development
    Table 86. Sekisui Diagnostics Company Detail
    Table 87. Sekisui Diagnostics Business Overview
    Table 88. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product
    Table 89. Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 90. Sekisui Diagnostics Recent Development
    Table 91. Response Biomedical Company Detail
    Table 92. Response Biomedical Business Overview
    Table 93. Response Biomedical Rapid Diagnostic Testing for InfluenzaProduct
    Table 94. Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 95. Response Biomedical Recent Development
    Table 96. SA Scientific Company Detail
    Table 97. SA Scientific Business Overview
    Table 98. SA Scientific Rapid Diagnostic Testing for InfluenzaProduct
    Table 99. SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 100. SA Scientific Recent Development
    Table 101. DiaSorin (Focus Diagnostics) Company Detail
    Table 102. DiaSorin (Focus Diagnostics) Business Overview
    Table 103. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for InfluenzaProduct
    Table 104. DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 105. DiaSorin (Focus Diagnostics) Recent Development
    Table 106. Wondfo Company Detail
    Table 107. Wondfo Business Overview
    Table 108. Wondfo Rapid Diagnostic Testing for InfluenzaProduct
    Table 109. Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 110. Wondfo Recent Development
    Table 111. Beijing Wantai Biological Pharmacy Company Detail
    Table 112. Beijing Wantai Biological Pharmacy Business Overview
    Table 113. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for InfluenzaProduct
    Table 114. Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2017-2022) & (US$ Million)
    Table 115. Beijing Wantai Biological Pharmacy Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rapid Diagnostic Testing for Influenza Market Share by Type: 2021 VS 2028
    Figure 2. Digital RIDTs Features
    Figure 3. Conventional RIDT Features
    Figure 4. Global Rapid Diagnostic Testing for Influenza Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. POCT Case Studies
    Figure 7. Others Case Studies
    Figure 8. Rapid Diagnostic Testing for Influenza Report Years Considered
    Figure 9. Global Rapid Diagnostic Testing for Influenza Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Rapid Diagnostic Testing for Influenza Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Rapid Diagnostic Testing for Influenza Market Share by Region: 2021 VS 2028
    Figure 12. Global Rapid Diagnostic Testing for Influenza Market Share by Players in 2021
    Figure 13. Global Top Rapid Diagnostic Testing for Influenza Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Rapid Diagnostic Testing for Influenza Revenue in 2021
    Figure 15. North America Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Rapid Diagnostic Testing for Influenza Market Share by Country (2017-2028)
    Figure 17. United States Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Rapid Diagnostic Testing for Influenza Market Share by Country (2017-2028)
    Figure 21. Germany Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Share by Region (2017-2028)
    Figure 29. China Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Rapid Diagnostic Testing for Influenza Market Share by Country (2017-2028)
    Figure 37. Mexico Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Share by Country (2017-2028)
    Figure 41. Turkey Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. BD Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 44. Abbot (Alere) Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 45. Quidel Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 46. Roche Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 48. Meridian Bioscience Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 49. Analytik Jena Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 50. Princeton BioMeditech Corporation Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 51. BioMerieux Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 52. Sekisui Diagnostics Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 53. Response Biomedical Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 54. SA Scientific Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 55. DiaSorin (Focus Diagnostics) Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 56. Wondfo Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 57. Beijing Wantai Biological Pharmacy Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed

Keyplayers in Global Rapid Diagnostic Testing for Influenza Market Research Report 2022

BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy